Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma

World Journal of Surgery

Volumn 36, Issue 8, 2012, Pages 1824-1831

  Muscari, Fabrice ^a,b   Guinard, Jean Pascal ^a   Kamar, Nassim ^a   Peron, Jean Marie ^c   Otal, Philippe ^a   Suc, Bertrand ^a  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; IMMUNOSUPPRESSIVE AGENT; TUMOR MARKER;

ARTICLE; BIOPSY; BLOOD; CANCER STAGING; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84866740057     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1587-z     Document Type: Article

References (47)

1. Yoo HY, Patt CH, Geschwind JF et al (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001:5-year survival has improved significantly with time. J Clin Oncol 21:4329-4335
2. Hemming AW, Cattral MS, Reed AI et al (2001) Liver transplantation for hepatocellular carcinoma. Ann Surg 5:652-659
3. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699
4. Jonas S, Bechstein WO, Steinmueller T et al (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080-1086
5. Figueras J, Jaurrieta E, Valls C et al (1997) Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25:1485-1489
6. Llovet JM, Bruix J, Fuster J et al (1998) Liver transplantation for small hepatocellular carcinoma: the tumour-node-metastasis classification does not have prognostic power. Hepatology 27:1572-1577
7. Herrero JI, Sangro B, Quiroga J et al (2001) Influence of tumour characteristic on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 7:631-636
8. Duffy JP, Vardanian A, Benjamin E et al (2007) Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246:502-511
9. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917
10. El-Serag HB, Mason AL (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
11. Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: an expansion of the tumour size limits does not adversely impact survival. Hepatology 33:1394-1403
12. Sue C, Kris V (2002) Expansion of criteria for liver transplantation in HCC: a slippery slope? Gastroenterology 122:579-582
13. Roayaie S, Frischer JS, Emre SH et al (2002) Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 cm. Ann Surg 235:533-539
14. Onaca N, Davis GL, Goldstein RM et al (2007) Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumor in Liver Transplantation. Liver Transpl 13:391-399
15. Muscari F, Foppa B, Kamar N et al (2009) Liberal selection criteria for liver transplantation for hepatocellular carcinoma. Br J Surg 96:785-791
16. Sugawara Y, Tamura S, Makuuchi M (2007) Living donor liver transplantation for hepatocellular: Tokyo University series. Dig Dis 25:310-312
17. Toso C, Kneteman NM, Shapiro AMJ et al (2009) The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria. Transpl Int 22:869-875
18. Cha C, Fong Y, Jarnagin WR et al (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197:753-758
19. Scatton O, Zalinski S, Terris B et al (2008) Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl 14:779-788
20. Regimbeau JM, Abdalla EK, Vauthey JN et al (2004) Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 85:36-41
21. Wang CC, Iyer SI, Low JK et al (2009) Perioperative factors affecting long term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 16:1832-1842
22. Ng KK, Lo CM, Liu CL et al (2008) Survival analysis of patients with transplantable recurrent hepatocellular carcinoma. Arch Surg 143:68-74
23. Pawlik TM, Gleisner AL, Anders RA et al (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245:435-442
24. Sherman M (2010) The resurrection of alphafetoprotein. J Hepatol 52:939-940
25. Fujioka M, Nakashima Y, Nakashima O et al (2001) Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma (abstract). Hepatology 34:1128-1134
26. Farinati F, Marino D, De Giorgo M et al (2006) Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 101:524-532
27. Vibert E, Azoulay D, Hoti E et al (2010) Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transpl 10:129-137
28. Toso C, Asthana S, Bigam DL et al (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 49:832-838
29. Wang ZX, Song SH, Teng F et al (2010) A single-center retrospective analysis of liver transplantation on 225 patients with hepatocellular carcinoma. Clin Transpl 24:752-757
30. Onaca N, Davis GL, Jennings LW et al (2009) Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in liver transplantation. Liver Transpl 15:574-580
31. Han K, Tzimas GN, Barkun JS et al (2007) Preoperative alphafetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol 21:39-45
32. Chen CL, Concejero AM (2010) Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. J Hepatobiliary Pancreat Sci 17:555-558
33. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference-European Association for the Study of Liver. J Hepatol 35:421-430
34. Muscari F, Suc B, Aguirre J et al (2005) Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portocaval anastomosis a justified procedure? Transpl Proc 37:2159-2162
35. Muscari F, Suc B, Vigouroux D et al (2005) Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int 18:1236-1239
36. Decaens T, Roudot-Thoroval F, Hadni-Bresson S et al (2006) Impact of UCSF criteria according to pre-and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 12:1769-1791
37. Sotiropoulos GC, Malago M, Molmenti EP et al (2005) Liver transplantation for hepatocellular carcinoma in cirrosis: is clinical tumor classification before transplantation realistic? Transplantation 79:483-487
38. Figueras J, Ibanez L, Ramos E et al (2001) Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl 7:877-883
39. Shetty K, Timmins K, Brensinger C et al (2004) Liver transplantation for hepatocellular carcinoma: validation of present selection criteria in predicting outcome. Liver Transpl 10:911-918
40. De Carlis L, Giacomoni A, Pirotta V et al (2003) Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 196:887-897
41. Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States: prognostic features, treatment, outcome and survival. Cancer 77:2217-2222
42. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434-1440
43. Yamashiki N, Gaynor JJ, Kato T et al (2004) Competing risks analysis of predictors of delisting owing to tumor progression in liver transplantation candidates with hepatocellular carcinoma. Am J Transpl 4:774-781
44. Shan SL, Mo FK, Johnson PJ et al (2009) New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. J Clin Oncol 27:446-452
45. Riaz A, Ryu RK, Kulik LM et al (2009) Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 27:5734-5742
46. Chen LT, Shiah HS, Chao Y et al (2009) Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent. J Clin Oncol 27:e271
47. Sandhu L, Sandroussi C, Guba M, et al (2011) Live donor versus decreased donor liver transplantation for hepatocellular carcinoma: comparative survival and recurrence. Liver Transpl Dec. 5